The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Most Popular Stories
- FDA Sends Warning Letter to Compounding Firm
- Australia Easy Juddmonte International Winner
- Brief Fair Meet at Timonium Begins Aug. 22
- The Jockey Club Elects Six New Members
- Haskin: Viva Travers!
- RCI Votes Increased Multiple NSAID Penalties
- Value in Young Sires at Keeneland September
- Shared Belief Looking to Retain His Throne
- Thoro-Graph Products Added to Equibase.com
- Big Three Clash in Rich Travers Stakes